Targeting CDK4 and CDK6 in cancer

S Goel, JS Bergholz, JJ Zhao - Nature Reviews Cancer, 2022 - nature.com
Abstract Cyclin-dependent kinase 4 (CDK4) and CDK6 are critical mediators of cellular
transition into S phase and are important for the initiation, growth and survival of many …

Lysosome biogenesis: Regulation and functions

C Yang, X Wang - Journal of Cell Biology, 2021 - rupress.org
Lysosomes are degradation centers and signaling hubs in cells and play important roles in
cellular homeostasis, development, and aging. Changes in lysosome function are essential …

CDK4 and CDK6 kinases: From basic science to cancer therapy

A Fassl, Y Geng, P Sicinski - Science, 2022 - science.org
BACKGROUND Cyclins and cyclin-dependent kinases (CDKs) drive cell division. Of
particular importance to the cancer field are D-cyclins, which activate CDK4 and CDK6. In …

Targeting autophagy in cancer

AV Onorati, M Dyczynski, R Ojha, RK Amaravadi - Cancer, 2018 - Wiley Online Library
Autophagy is a conserved, self‐degradation system that is critical for maintaining cellular
homeostasis during stress conditions. Dysregulated autophagy has implications in health …

Fasting-mimicking diet and hormone therapy induce breast cancer regression

I Caffa, V Spagnolo, C Vernieri, F Valdemarin… - Nature, 2020 - nature.com
Approximately 75% of all breast cancers express the oestrogen and/or progesterone
receptors. Endocrine therapy is usually effective in these hormone-receptor-positive …

Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant Pancreatic Cancer

CM Goodwin, AM Waters, JE Klomp, S Javaid… - Cancer …, 2023 - aacrjournals.org
Mutational loss of CDKN2A (encoding p16INK4A) tumor-suppressor function is a key
genetic step that complements activation of KRAS in promoting the development and …

Mechanisms of sensitivity and resistance to CDK4/6 inhibition

M Álvarez-Fernández, M Malumbres - Cancer cell, 2020 - cell.com
Inhibiting the cell-cycle kinases CDK4 and CDK6 results in significant therapeutic effect in
patients with advanced hormone-positive breast cancer. The efficacy of this strategy is …

Cyclin E1 expression and palbociclib efficacy in previously treated hormone receptor–positive metastatic breast cancer

NC Turner, Y Liu, Z Zhu, S Loi, M Colleoni… - Journal of Clinical …, 2019 - ascopubs.org
PURPOSE A large-panel gene expression analysis was conducted to identify biomarkers
associated with the effectiveness of adding palbociclib to fulvestrant. METHODS The …

CDK4/6 inhibition in cancer: beyond cell cycle arrest

S Goel, MJ DeCristo, SS McAllister, JJ Zhao - Trends in cell biology, 2018 - cell.com
Pharmacologic inhibitors of cyclin-dependent kinases 4 and 6 (CDK4/6) have recently
entered the therapeutic armamentarium of clinical oncologists, and show promising activity …

Cellular senescence: molecular targets, biomarkers, and senolytic drugs

N Kudlova, JB De Sanctis, M Hajduch - International Journal of Molecular …, 2022 - mdpi.com
Cellular senescence is defined as irreversible cell cycle arrest caused by various processes
that render viable cells non-functional, hampering normal tissue homeostasis. It has many …